0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lamotrigine"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Bipolar Disorder Drugs And Treatment Global Market Report 2025 - Product Thumbnail Image

Bipolar Disorder Drugs And Treatment Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$5,850USDGBP
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
EUR$2,160USDGBP
EUR$2,400USDGBP
From
EUR$6,499USDGBP
From
EUR$7,500USDGBP
  • 7 Results (Page 1 of 1)
Loading Indicator

Lamotrigine is an anticonvulsant drug used to treat mental disorders such as bipolar disorder, depression, and schizophrenia. It is also used to treat seizures in adults and children. Lamotrigine works by stabilizing electrical activity in the brain, which helps to reduce the frequency and severity of seizures and mood swings. It is available in both generic and brand-name forms. The Lamotrigine market is a competitive one, with many companies offering their own versions of the drug. It is widely prescribed by doctors and is generally well-tolerated by patients. Common side effects include dizziness, headache, nausea, and rash. Companies in the Lamotrigine market include GlaxoSmithKline, Pfizer, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more